Fabian Vandermeers

The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells<i>in vitro</i>and<i>in vivo</i>with particular efficacy for small cell lung cancer

M. Cecilia Crisanti, Africa F. Wallace, Veena Kapoor et al. · Molecular Cancer Therapeutics · 2009 · 111 citations · Full text

Valproate, in Combination with Pemetrexed and Cisplatin, Provides Additional Efficacy to the Treatment of Malignant Mesothelioma

Fabian Vandermeers, Pascale Hubert, Philippe Delvenne et al. · Clinical Cancer Research · 2009 · 89 citations · Full text

Present Chemotherapeutic Regimens, Malignant Mesothelioma, Medicine +14

Valproate activates bovine leukemia virus gene expression, triggers apoptosis, and induces leukemia/lymphoma regression <i>in vivo</i>

Amine Achachi, Arnaud Florins, Nicolas Gillet et al. · Proceedings of the National Academy of Sciences · 2005 · 66 citations · Full text

Preclinical evidence for a beneficial impact of valproate on the response of small cell lung cancer to first-line chemotherapy

Roland Hubaux, Fabian Vandermeers, Cecilia Crisanti et al. · European Journal of Cancer · 2010 · 39 citations

Oncology, Medicine, Preclinical Evidence +8

Valproic acid improves second-line regimen of small cell lung carcinoma in preclinical models

Roland Hubaux, Fabian Vandermeers, Jean-Philippe Cosse et al. · ERJ Open Research · 2015 · 14 citations · Full text

Tumor Biology, Oncology, Anti-cancer Agent +17